Clinical trial

A Study of NTRX-07 in Participants With Alzheimer's Disease

NCT07058688

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-03-01

PhasePHASE2

Study timeline

Study start (actual)2025-03-01Date precision: day

Registry last updated2025-07-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Mild Cognitive Impairmentunresolved

Interventions

NTRX-07DRUG

PlaceboDRUG

Sponsors & collaborators

NeuroTherapia, Inc.lead sponsor

Cruint Global Consulting Pte Ltdcollaborator

Firalis SAcollaborator

Pharma-Regist Kft.collaborator

Mapped research locations

BudapestHungary2 PragueCzechia1 KrakowPoland1 WroclawPoland1 BrnoCzechia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07058688 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.